FDA and EMA Requirements for Protocol Amendments Compared
FDA and EMA Requirements for Protocol Amendments Compared Comparing FDA and EMA Requirements for Protocol Amendments Why Understanding Regional Differences Matters In global clinical trials, sponsors often submit protocol amendments to multiple regulatory bodies. The United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have distinct definitions, procedures, and timelines governing…
Read More “FDA and EMA Requirements for Protocol Amendments Compared” »